- Home
- DXCM vs ARE Comparison
DXCM vs ARE Comparison
Compare DXCM & ARE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | DXCM | ARE |
|---|---|---|
| Founded | 1999 | 1994 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Medical/Dental Instruments | Real Estate Investment Trusts |
| Sector | Health Care | Real Estate |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 25.9B | 8.8B |
| IPO Year | 2005 | 1997 |
Fundamental Metrics
Financial Performance| Metric | DXCM | ARE |
|---|---|---|
| Price | $66.84 | $46.49 |
| Analyst Decision | Strong Buy | Hold |
| Analyst Count | 21 | 10 |
| Target Price | ★ $87.90 | $69.38 |
| AVG Volume (30 Days) | ★ 5.3M | 3.1M |
| Earning Date | 10-30-2025 | 01-26-2026 |
| Dividend Yield | N/A | ★ 10.03% |
| EPS Growth | ★ 7.75 | N/A |
| EPS | ★ 1.80 | N/A |
| Revenue | ★ $4,515,900,000.00 | $3,058,395,000.00 |
| Revenue This Year | $17.41 | N/A |
| Revenue Next Year | $12.78 | N/A |
| P/E Ratio | $37.27 | ★ N/A |
| Revenue Growth | ★ 14.21 | N/A |
| 52 Week Low | $54.11 | $44.10 |
| 52 Week High | $93.25 | $105.14 |
Technical Indicators
Market Signals| Indicator | DXCM | ARE |
|---|---|---|
| Relative Strength Index (RSI) | 60.62 | 33.16 |
| Support Level | $64.00 | $44.10 |
| Resistance Level | $69.77 | $47.19 |
| Average True Range (ATR) | 1.96 | 1.68 |
| MACD | 0.78 | 0.28 |
| Stochastic Oscillator | 72.06 | 24.13 |
Price Performance
Historical ComparisonAbout DXCM DexCom Inc.
DexCom designs and commercializes continuous glucose monitoring systems for diabetic patients. CGM systems serve as an alternative to the traditional blood glucose meter process, and the company is evolving its CGM systems to provide integration with insulin pumps from Insulet and Tandem for automatic insulin delivery.
About ARE Alexandria Real Estate Equities Inc.
Alexandria Real Estate Equities Inc is an urban office real estate investment trust (REIT). It is engaged in the business of providing space for lease to life science, agtech, and technology tenants. The company has established a market presence in key locations, including Greater Boston, the San Francisco Bay Area, New York City, San Diego, Seattle, Maryland, and Research Triangle, Texas, and Canada. The Company is a life science real estate investment trust focused on developing, redeveloping, and operating properties that provide space for lease to tenants in the life science industry.